Biocept Profit Margin

As of the most recent data (June 2023), BIOCQ shows a profit margin of 1015.77%. That compares with -17.29% in the prior-year period — up 5975.5% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOCQ's profit margin is now 1015.77% (was -17.29%) — a 5975.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biocept is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Biocept is at 1015.77%, which is higher that average. That is roughly 6981.1% above the sector mean. Use the comparison chart on this page to see how BIOCQ stacks up against individual peers as well.

That compares with -17.29% in the prior-year period — up 5975.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biocept with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Biocept's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 1015.77%) with ownership activity and broader fundamentals.